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Abstract
The proteins P52 and P36 are expressed in the sporozoite stage of the murine malaria parasite Plasmodium berghei.
Dp52&p36 sporozoites lacking expression of both proteins are severely compromised in their capability to develop into liver
stage parasites and abort development soon after invasion; presumably due to the absence of a parasitophorous vacuole
membrane (PVM). However, a small proportion of P. berghei Dp52&p36 parasites is capable to fully mature in hepatocytes
causing breakthrough blood stage infections. We have studied the maturation of replicating Dp52&p36 parasites in cultured
Huh-7 hepatocytes. Approximately 50% of Dp52&p36 parasites developed inside the nucleus of the hepatocyte but did not
complete maturation and failed to produce merosomes. In contrast cytosolic Dp52&p36 parasites were able to fully mature
and produced infectious merozoites. These Dp52&p36 parasites developed into mature schizonts in the absence of an
apparent parasitophorous vacuole membrane as shown by immunofluorescence and electron microscopy. Merozoites
derived from these maturing Dp52&p36 liver stages were infectious for C57BL/6 mice.
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Introduction
Plasmodium sporozoites are transmitted to the mammalian host
by the bites of infected Anopheline mosquitoes. The parasites leave
the injection site and make their way to the liver where they invade
hepatocytes before commencing the erythrocytic cycle. There are
two distinct pathways by which Plasmodium sporozoites enter
hepatocytes: they either migrate through cells disrupting the host
cell membrane, or they invaginate the host cell membrane forming
a parasitophorous vacuole (PV) and a parasitophorous vacuole
membrane (PVM) [1]. Proper formation and subsequent modifi-
cation of the PV and PVM are considered crucial for development
and survival of intrahepatic parasites [2]. Nonetheless, a small
proportion of Plasmodium parasites is capable of (partial) intranu-
clear development [3,4] in the absence of a PVM [4]. After
invasion of the hepatocyte the sporozoites multiply and form tens
of thousands of merozoites, which are released into the blood-
stream as merosomes.
Both the Plasmodium genes p52, encoding a putative GPI-
anchored protein [5,6] and its paralogous gene p36, encoding a
putative secreted protein [6] are upregulated in sporozoite stages
[7] with a putative function in hepatocyte invasion. P. berghei and P.
yoelii parasites, genetically attenuated by the deletion of the p52
gene or the p36 gene, lack a PVM upon hepatocyte invasion [5,8].
These mutant parasites are severely compromised in their
capability to develop into liver cells and abort development soon
after invasion. The developmental arrest of these Dp52&p36
mutant parasites was confirmed in P. falciparum [7]. Infection of
mice with high numbers of P. yoelii Dp52&p36 sporozoites, does
not result in a blood stage infection [8]. The developmental arrest
of these knock-out parasites is thought to be related to the lack of a
PVM, considered critical for intracellular survival in hepatocytes.
Despite the apparent full developmental arrest, we previously
showed that a low percentage of Dp52 [5] and Dp52&p36 [9]
parasites are able to generate a blood stage infection in the P.
berghei murine model. Moreover, we provided evidence that low
numbers of Dp52&p36 P. falciparum sporozoites, develop into
replicating liver stages [9].
In this study we followed replicating Dp52&p36 parasites in the
course of hepatic maturation and more specifically in relation to
intranuclear location and PVM development.
Materials and Methods
Mice and Parasites
Female C57BL/6J, eight weeks of age, were purchased from
Elevage Janvier (France). All studies in which animals were
involved have been performed according to the regulations of the
Dutch ‘‘Animal On Experimentation act’’ and the European
Directive 2010/63/EU.
The P. berghei Dp52&p36 and wildtype (P. berghei ANKA)
parasites used are described elsewhere [9].
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Analysis of in vitro P. berghei Liver-stage Development
by Immunofluorescence
P. berghei sporozoites were collected at day 21 after mosquito
infection by hand-dissection of salivary glands. Salivary glands
were collected in DMEM (Dulbecco’s Modified Eagle Medium
from GIBCO) and homogenized in a homemade glass grinder.
The number of sporozoites was determined by counting samples in
duplicate in a Bu¨rker-Tu¨rk counting chamber using phase-contrast
microscopy.
Liver stage development of the P. berghei mutants and wildtype
parasites was determined in vitro as described previously [9].
Briefly, human liver hepatoma cells (Huh-7 [10]) were suspended
in 1 ml of ‘complete’ DMEM (DMEM, Gibco, supplemented with
10% FCS, 1% penicillin/streptomycin and 1% Glutamax) and
were seeded on coverslips in 24-well plates (105 cells/well). After
Huh-7 monolayers were.80% confluent, 56104 sporozoites were
added per well, and centrifuged 10 minutes at 18006G (eppendorf
centrifuge 5810 R). At different time points after infection, cells
were fixed with 4% paraformaldehyde, permeabilized with 0.1%
Triton-X-100, blocked with 10% FCS in PBS, and subsequently
stained with a primary and secondary antibody at room
temperature for 45 and 30 min respectively. Primary antibodies
used were anti-PbUIS-4 (raised in rabbit; [11], detecting a PVM-
resident protein); anti-PbHSP70 (raised in mouse; [5], detecting
the parasite cytoplasmic heat-shock protein 70 and anti-PbMSP-1
(raised in mouse; MRA-667 from MR4; www.MR4.org), detecting
the merozoite surface protein 1 of P. berghei. The anti-UIS-4
antibody were preferred over the earlier described anti-EXP-1
antibody [9], detecting another PVM resident protein because of
the intensity and the constitutive expression. Anti-mouse and anti-
rabbit secondary antibodies, conjugated to Alexa-488 and Alexa-
594, were used for visualization (Invitrogen). Nuclei were stained
with DAPI. Analysis of infected hepatocytes was performed using a
Zeiss Axiophot Fluorescence microscope with Axiocam MRm
CCD (Fig. 1C and Fig S1) camera or a Olympus FV1000
Confocal Laser Scanning Microscope.
TEM Analysis of Infected Huh-7 Cells
For ultrathin-section transmission electron microscopy,
26105 wt and 56105 p52/p36-deficient sporozoites were used to
infect 3.56105 sub-confluent Huh-7 cells, seeded the day prior in
35 mm petridishes. Sporozoites were centrifuged for 10 minutes at
18006G and 32 hours post infection cells were fixed in 2.5%
glutaraldehyde (Electron Microscopy Sciences) in 0.1 M sodium
cacodylate buffer (pH 7.4) for 1 h at room temperature and
subsequently washed three times for 10 minutes in 0.1 M sodium
cacodylate buffer and then post-fixed for 1 h in 1% osmium
tetroxide (Electron Microscopy Sciences, Gibbstown, NY) in
sodium cacodylate buffer at room temperature. Samples were
washed three times 20 minutes in 0.1 M sodium cacodylate buffer
and subsequently dehydrated in a graded series (10-50-70-96-
100%) of ethanol. Cells were resin infiltrated in a 100% ethanol/
EPON (Sigma) mixture (2:1) for 3 hours and subsequently in a
100% ethanol/EPON mixture (1:1) for 5 hours and subsequently
in pure EPON overnight. Beem capsules were placed onto the cells
perpendicular, filled with EPON, and polymerized overnight at
60uC. Ultrathin (50–100 nm) sections were cut parallel to the cell
surface using an Ultracut ultramicrotome (Leica, Germany) and
contrasted with 2% uranyl acetate and lead citrate before
examination with a JEOL 1010 microscope under 60 kV.
Analysis of Infectivity of Huh-7 Hepatoyte-derived
Merozoites
Assessment of the infectivity of hepatocyte derived merozoites
has previously been described for PbDlisp1 mutants [12]. The
protocol was adapted and Huh-7 cells were seeded in a 24-wells
plate at 106 cells/well, overnight. Sporozoites were added to the
wells (.80% confluent) at 86104 sporozoites per well, and
centrifuged 10 minutes at 18006G (eppendorf centrifuge 5810 R).
65 hours post infection 100 ml supernatants were collected from
each well, centrifuged for 3 minutes at 12.000 rpm and the cell
pellet was re-suspended in 100 ml RPMI. A total of 200 ml re-
suspended culture supernatant (from 2 wells) was injected i.v per
C57BL/6 mice. Approval was obtained from the Radboud
University Experimental Animal Ethical Committee (RUDEC
2009-225). Blood stage infections were monitored by Giemsa
staining of blood smears from day 2 up to day 14 post injection.
Genotype confirmation of Dp52&p36 and wildtype parasites was
performed as described [9]. The pre-patent period was defined as
the period of time (days) between injection and the day that mice
showed a blood stage parasitemia of 0.5–2%.
Results
P. berghei Dp52&p36 Parasites can Partially Develop
Inside the Nucleus of the Hepatocyte
In vitro analysis of P. berghei infected Huh-7 hepatocyte cultures
showed that compared to wildtype (100%), a low proportion of
Dp52&p36 sporozoites, (260.6% (p,0.01)) was able to develop
into replicating intra-hepatic parasites (Fig. 1a, Table S1). Most
knockout parasites (98%) abort development soon after invasion
and do not start nuclear replication.
Remarkably, a relatively large proportion of the replicating
Dp52&p36 parasites, 45% (60.7%) resided inside the nucleus of
hepatocytes, compared to 1.25% (60.35%) of intranuclear
wildtype parasites (p,0.01) at 24 hours post invasion (Fig. 1a,
Table S1). The absolute number of intranuclear mutant parasites
matched the number of wildtype parasites. For both wildtype and
mutant parasites, there was a slight decrease in the percentage of
intranuclear developing parasites during the course of parasite
maturation. At any time point, however, while the absolute
number remained the same, the percentage of intranuclear mutant
parasites was significantly higher than the percentage of intranu-
clear wildtype parasites (p,0.05) (Fig. 1a).
Intranuclear developing P. berghei wildtype and Dp52&p36
parasites were negative for UIS-4 peripheral staining, a marker for
thepresenceofaPVM(Fig.1b)anddidnotexpressMSP-1at52hours
post infection, as depicted by an intranuclear Dp52&p36 parasite
(Fig. 1c). At time points up to 72 hours post infection, these parasites
remained negative (data not shown) indicating that the absence of
MSP1staining isnot theresults of adelay inmaturationperiod.Based
onMSP-1 expression, intranuclear parasites are unlikely the cause of
Dp52&p36 parasite breakthrough in mice.
Cytosolic Dp52&p36 Parasites can Produce Mature
Merozoites in the Absence of an Apparent PVM
More thanhalfof thereplicatingDp52&p36parasites resided inthe
cytosol of Huh-7 hepatocytes (Fig. 1a) expressing MSP-1 and
transforming into mature merozoites from 52 hours post invasion
onwards. These cytosolic Dp52&p36 parasites did not show the
typical round shape of wildtype parasites, but were instead
characterizedbyan irregularmorphology (Fig.2a,FigS1). Individual
merosomes were clearly visible budding of from the infected
hepatocyte (Fig S1 right box). Replicating cytosolic Dp52&p36
Cytosolic Dp52&p36 P. berghei Lack Apparent PVM
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parasites (n = 498)were negative for peripheralUIS-4 staining at any
timepoint starting fromearly liver infectiononwards (6–52hour post
invasion) (Fig. 2b). Using transmission electron microscopy at 32
hours post infection, we observed cytosolic wildtype parasites
demarked by a surrounding PV and PVM, while, in contrast, both
PV and PVM could not be detected inDp52&p36 parasites (Fig. 2c).
Thus,Dp52&p36 parasites replicating in the cytosol expressedMSP-
1, but lacked an apparent PVM.
Hepatocyte Derived Dp52&p36 Merozoites are able to
Induce a Blood Stage Infection
We next tested whether Dp52&p36 parasites developing into
merozoites were capable of infecting erythrocytes. Therefore,
supernatants of Dp52&p36 and wildtype infected Huh-7 cells,
collected 65 hours post infection, were injected i.v in C57BL/6mice
(Table 1). All mice injected with culture supernatant became patent
with blood stage parasitemia as determined by thick smear.
Genotyping of blood parasites confirmed the Dp52&p36 genotype
(Fig. S2). Themean difference in day of patency betweenDp52&p36
and wildtype parasites i.e. 5.9 versus 2.4 days post injection
respectively, likely reflects the difference in number of viable
merozoites injected. These data show that Dp52&p36 parasites,
developing inHuh-7hepatocytes in theabsenceofanapparentPVM,
are capable of maturing into infectious merozoites.
Discussion
Here we show that a proportion of P. berghei Dp52&p36 parasites
can develop inHuh-7 hepatocytes in the apparent absence of a PVM
and fullymature intomerozoites.Merozoites derived froman in vitro
Dp52&p36 hepatocyte culture were infectious and lead to a blood
stage infection in mice. Our data question the absolute necessity for
the presence of a PVM for intrahepatic P. berghei development.
Although all observed replicating Dp52&p36 parasites herein
(approximately 900 by immunofluorescence) develop free of PVM
inside the hepatocytes, one cannot formally exclude the possibility
Figure 1. Intranuclear development of Dp52&p36 P. berghei parasites. A) Pie diagrams of intranuclear and cytosolic wildtype and mutant
replicating parasites at 24, 36 and 48 hours post invasion in Huh-7 cells. The diameter of the circles represents the relative number of replicating
parasites observed per coverslip, where the wildtype circle at 24 hour represent 100% and all other circles are deduced (wildtype = 1300–1500 and
Dp52&p36= 20–40 replicating parasites per coverslip at 24 hours post infection. Absolute numbers are depicted in Table S1 B) UIS-4 and HSP70
expression on an intranuclear P. berghei parasite 44 hours post infection (Bar = 10 mm). C) MSP-1 expression on intranuclear (Dp52&p36) and cytocolic
(wildtype) P. berghei parasites 52 hours post infection (Bar = 10 mm).
doi:10.1371/journal.pone.0050772.g001
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that a small proportion of the P. berghei mutants develop with a
PVM into infectious merozoites. Nonetheless, the breakthrough
blood stage parasites were infectious for mosquitoes and upon re-
infection of a hepatocyte culture with sporozoites, all replicating
mutants lacked UIS-4 staining (data not shown). This indicates
that the infectious merozoites did not arise from a subset of mutant
parasites that stably switched to a phenotype of forming a PVM in
the absence of P52 or P36.
The relatively high percentage of mutant parasites replicating in
the hepatocyte nucleus seems remarkable. However, despite an
apparent preference of the mutant parasites to replicate in the
nucleus, the absolute number of intranuclear replicating mutants
does not differ from wildtype. Thus, mutant parasites do not
preferentially invade the nucleus of hepatocytes.
The seemingly preference for intranuclear development merely
arises from the developmental arrest of a major part of the
cytosolic mutant parasites. Intranuclear mutants have a develop-
mental advantage over cytosolic mutant parasites and their
numbers seem untouched by the absence of a PVM. Possibly,
the nuclear envelope acts as a substitute for the PVM.
The intranuclear mutant and wildtype P. berghei parasites likely
halt inside the nucleus of the hepatocyte upon transmigration,
similar to P. yoelii and P. falciparum [4]. These parasites do probably
not play a role in the observed breakthrough infections in mice.
Based on MSP-1 expression, cytosolic and not intranuclear
parasites are the likely source of infectious merozoites. Neverthe-
less, we cannot exclude that merozoites may arise from
intranuclear developing parasites.
Whereas Plasmodium parasites replicating in the nucleus in the
apparent absence of a PVM have previously been reported,
cytosolic parasites have not. Interestingly, upon close examination
of wildtype parasites, a small percentage (61.5% n=27) of the
cytosolic wildtype parasites lack peripheral UIS-4 staining at 30
hour post infection, similar to the cytosolic Dp52&p36 parasites
(data not shown). These data support the possibility of a non-
conventional intra-hepatic pathway for P. berghei development.
In the absence of an encompassing membrane cytosolic
parasites are likely more vulnerable to host defense mechanisms.
Genes involved in the evasion of host cell apoptosis [13,14] might
be less effective to avert cell death. Possibly, replicating mutant
parasites survive in an equilibrium of anti-apoptotic gene
expression and host defense mechanism.
It remains to be seen whether these findings in P. berghei are
representative for other Plasmodium species. Fully developing
cytosolic parasites absent of a PVM have, to our knowledge,
never been reported for any of the other Plasmodium species. While
P. yoelii Dp52&p36 breakthrough has not been reported, Labaied
et al. previously described a multi-nucleated P. yoelii ‘growth
arrested’ Dp52&p36 parasite in a Hepg2-CD81 cell [8], a human
hepatoma cell line that promotes the formation of a PVM by P.
yoelii [4]. This particular parasite lacked a peripheral UIS-4
expression [8]. Apparently, very low numbers of the mutant P.
yoelii parasites still replicate inside Hepg2-CD81 cells in the
absence of a PVM. Furthermore, it will be interesting to see
whether the low numbers of mutant Dp52&p36 P. falciparum
parasites that replicate in primary human hepatocytes [9] have a
similar phenotype as the P. berghei mutants.
Our findings are confined to an in vitro Huh-7 P. berghei model
and the in vivo relevance of these findings remains elusive. In vivo
characterization is hampered by the extremely low number of
replicating parasites. Similarly, P. yoelii and P. falciparum replicating
Dp52&p36 parasites are extremely rare and at present their
mechanism of breakthrough remains unclear. Nevertheless, once
confirmed in P. falciparum, our findings may have implications for
Figure 2. Cytosolic developing Dp52&p36 P. berghei parasites
lack an apparent PVM. A) MSP-1 expression on cytosolic wildtype
and Dp52&p36 P. berghei parasites 52 hours post infection (Bar
= 10 mm). B) UIS-4 and HSP70 expression on cytosolic Dp52&p36 and
wildtype P. berghei parasites at 6–52 hours post infection (Bar = 10 mm).
C) Electron microscopic analysis of cytosolic wildtype (upper row) and
Dp52&p36 (lower row) parasites, 32 hours post hepatocyte infection.
The inset boxes show higher magnifications of the boxed areas within
the overview images. IMC, inner membrane complex; Ly lysosome; NE,
Nuclear envelope; PPM, parasite plasma membrane; PV, parasitophor-
ous vacuole; PVM, parasitophorous vacuole membrane; Rh, rhoptry (Bar
= 10 mm).
doi:10.1371/journal.pone.0050772.g002
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the development of a genetically attenuated malaria vaccine.
Based on protective efficacy conferred in mice and apparent full
arrest in P. yoelii and P. falciparum models, genetically attenuated
Dp52&p36 parasites have been considered eligible for clinical
development as an attenuated sporozoite vaccine [7]. Given the
break-through infections, our data suggest that for a sufficiently
attenuated malaria vaccine, multiple genes need to be targeted.
Such genes could not only include genes involved in the formation
of the PVM, but preferably other Plasmodium gene targets with
independent functions for liver stage development.
Supporting Information
Figure S1 Late liver stage intracytosolar Dp52&p36p
parasites have an irregular shape. Four representative
images of Dp52&p36p P. berghei parasites in culture 48 hours post
invasion in Huh-7 cells. Msp-1 expression is depicted in red, DAPI
in blue (Bar = 10 mm).
(TIF)
Figure S2 Confirmation of Dp52+p36 and wildtype geno-
type after merosome injection assay. A) Diagnostic PCR for
confirmation of correct disruption of p52 and p36 in mutant
Dp52+p36 (1409cl1). SM: selectable marker (primers 4501/4502;
1093bp); 59-integration event (primers L1389/L313; 1050bp);ORF
(primers L775/L121; 1029bp). B) Sequence of the primers used. C)
Southern analysis of pulse field gel (PFG)-separated chromosomes of
mutant Dp52+p36. Mutant Dp52+p36 has been generated in the
reference P. berghei ANKA line PbGFP-Luccon which has a gfp-
luciferase gene integrated into the silent 230p locus
(PBANKA_030600) on chromosome 3 (i.e. RMgm-29; http://
pberghei.eu/index.php?rmgm=29). Hybridization with the 39-
UTR dhfr/ts probe recognizes the integrated construct on chromo-
some9, thereporterGFP-Lucconconstructonchromosome3,andthe
endogenous dhfr/ts gene located on chromosome 7.
(TIF)
Table S1 Quantitative analysis of replicating intranuclear and
cytosolic wildtype and mutant parasites. a Average number of
replicating liver stage parasites per coverslip. A total of 3 coverslips
was counted per timepoint per parasite.
(DOC)
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